chitosan has been researched along with Depression in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, PF; Liu, XY; Qi, XJ; Qiu, F; Tang, LM; Yang, AH | 1 |
| Abd Rabo, AA; Abd-El Daim, TM; Elfeky, AS; Fahmy, HM; Khadrawy, YA; Mostafa, IT; Mustafa, AB | 1 |
| Abbas, H; El-Naa, M; Kamel, R | 1 |
| da Costa Araújo, AP; da Silva, IC; de Melo, NFS; Estrela, FN; Fraceto, LF; Guimarães, ATB; Lima, VS; Malafaia, G | 1 |
| Mishra, D; Nagpal, K; Singh, SK | 1 |
| Hallan, SS; Mehra, NK; Mishra, N; Prakash, A; Rashid, M; Singh, D | 1 |
6 other study(ies) available for chitosan and Depression
| Article | Year |
|---|---|
Anti-depressant effect of curcumin-loaded guanidine-chitosan thermo-sensitive hydrogel by nasal delivery.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Chitosan; Curcumin; Depression; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Guanidine; Hydrogels; Male; Mice; Mice, Inbred ICR; Solubility; Temperature; Viscosity | 2020 |
Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model.
Topics: Animals; Benzoquinones; Chitosan; Depression; Disease Models, Animal; Nanoparticles; Polysorbates; Rats; Reserpine | 2020 |
Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.
Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Chitosan; Citalopram; Delayed-Action Preparations; Depression; Drug Liberation; Male; Nanostructures; Pectins; Polyelectrolytes; Rats; Selective Serotonin Reuptake Inhibitors | 2018 |
Depression, anxiety-like behavior, and memory impairment in mice exposed to chitosan-coated zein nanoparticles.
Topics: Animals; Anxiety; Behavior, Animal; Chitosan; Depression; Male; Memory Disorders; Mice; Nanoparticles; Zein | 2019 |
Evaluation of safety and efficacy of brain targeted chitosan nanoparticles of minocycline.
Topics: Animals; Anti-Bacterial Agents; Antidepressive Agents; Behavior, Animal; Brain; Chitosan; Depression; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Drug Repositioning; Hindlimb Suspension; Locomotion; Male; Mice; Minocycline; Monoamine Oxidase; Nanoparticles; Polysorbates; Rats; Treatment Outcome | 2013 |
Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Chitosan; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Nanoparticles; Rats; Rats, Wistar; Selegiline | 2016 |